People · Operator

Thomas F. Zindrick

Named in public records as an officer, director or promoter · active 2017–2017 · Biotechnology

1
Companies
1
Filings
$14.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Aeromics, Inc.BiotechnologySeries A$14.1M$340.3M2017
Operator network

Thomas F. Zindrick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Christine F. Antalik · 1 companies · 1 sharedChristine F. Anta…Frederick F. Jones · 1 companies · 1 sharedFrederick F. JonesGeorge F. Farr · 1 companies · 1 sharedGeorge F. FarrJeff F. Draime · 1 companies · 1 sharedJeff F. DraimeJeffrey F. Draime · 1 companies · 1 sharedJeffrey F. DraimeJohn F. Foster · 1 companies · 1 sharedJohn F. FosterMarc F. Pelletier · 1 companies · 1 sharedMarc F. PelletierMarc Pelletier · 1 companies · 1 sharedMarc PelletierMark F. Day · 1 companies · 1 sharedMark F. DayPaul F. McGuirk · 1 companies · 1 sharedPaul F. McGuirkPaul F. Schlather · 1 companies · 1 sharedPaul F. SchlatherPeter F. Longo · 1 companies · 1 sharedPeter F. LongoWalter Boron · 1 companies · 1 sharedWalter BoronWalter F. Boron · 1 companies · 1 sharedWalter F. BoronAeromics, Inc. · $14.1M raisedAeromics, Inc.Thomas F. ZindrickTZ
Thomas F. Zindrick Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Thomas F. Zindrick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Walter Boron11
Marc Pelletier11
Frederick F. Jones11
Paul F. McGuirk11
Peter F. Longo11
Walter F. Boron11
George F. Farr11
Marc F. Pelletier11
John F. Foster11
Jeffrey F. Draime11
Mark F. Day11
Christine F. Antalik11
Paul F. Schlather11
Jeff F. Draime11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.